IDEXX EVP Nimrata Hunt sells 2,693 shares

IDEXX Laboratories Executive Vice President Nimrata Hunt reported an open-market sale of common stock.

Rhea-AI Filing Summary

IDEXX Laboratories Executive Vice President Nimrata Hunt reported an open-market sale of common stock. On February 26, 2026, Hunt sold 2,693 shares at a weighted average price of $661.5413 per share in open-market transactions. After the sale, Hunt directly owned 19,898.944 common shares and indirectly owned 160 shares jointly with a spouse. A footnote explains that the sale prices ranged from $661.35 to $661.8275 per share, with detailed trade breakdowns available upon request.

Insider Trade Summary

Net Seller: 2,693 shares

Net Sell 2 txns

Insider Hunt Nimrata

Role Executive Vice President

Sold 2,693 shs ($1.78M)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,693	$661.5413	$1.78M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 19,898.944 shares (Direct); Common Stock — 160 shares (Indirect, jointly with spouse)

Footnotes (1)

1. F1. Represents the weighted average price of the shares sold ranging from a low of $661.35 to a high of $661.8275 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IDEXX (IDXX) Executive Vice President Nimrata Hunt report on this Form 4?

Nimrata Hunt reported selling IDEXX common stock in an open-market transaction. The filing shows a sale of 2,693 shares on February 26, 2026, and updates Hunt’s direct and indirect ownership positions after the trade.

How many IDEXX (IDXX) shares did Nimrata Hunt sell and at what price?

Hunt sold 2,693 shares of IDEXX common stock at a weighted average price of $661.5413 per share. A footnote notes individual trade prices ranged from $661.35 to $661.8275, with full price-by-trade details available upon request.

How many IDEXX (IDXX) shares does Nimrata Hunt own after this reported sale?

Following the reported sale, Hunt directly holds 19,898.944 shares of IDEXX common stock. The filing also shows indirect ownership of 160 additional shares held jointly with a spouse, reflecting total reported holdings after the transaction.

What type of transaction did Nimrata Hunt report in IDEXX (IDXX) stock?

The Form 4 describes an open-market sale of IDEXX common stock. The transaction is coded as “S,” indicating a sale in the open market or a private transaction, with the normalized description stating it was an open-market sale of non-derivative shares.

Does the IDEXX (IDXX) Form 4 disclose any indirect holdings by Nimrata Hunt?

Yes. In addition to directly held shares, the filing reports 160 IDEXX common shares held indirectly. These are described as owned “jointly with spouse,” indicating a shared ownership arrangement separate from Hunt’s direct shareholdings.

What pricing details are provided for Nimrata Hunt’s IDEXX (IDXX) share sale?

The filing reports a weighted average sale price of $661.5413 per share. A footnote clarifies actual sale prices ranged between $661.35 and $661.8275, and states that a full breakdown of share amounts at each price will be provided upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 05:03 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hunt Nimrata

(Last) (First) (Middle)

ONE IDEXX DRIVE

(Street)

WESTBROOK ME 04092

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		S		2,693	D	$661.5413(1)	19,898.944	D
Common Stock								160	I	jointly with spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the weighted average price of the shares sold ranging from a low of $661.35 to a high of $661.8275 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Remarks:

	/s/ Lily J. Lu, Attorney-in-Fact for Nimrata Hunt	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.